| Age |
63.5 (35-81) years |
| M:F |
7:5 |
| BMI |
23.2 (18.8-39.9) kg/m2 |
| ICM:NICM |
7:5 |
| Intermacs profile 1 or 2 |
7 (58%) |
| Device Strategy: BTT |
8 (75%) |
| Duration of MCS |
50 (1-863) days |
| Mechanical Ventilation |
5 (42%) |
| Inotropes, Vasopressors |
5 (42%) |
| Hemodialysis |
3 (25%) |
| Prior abdominopelvic surgery |
5 (42%) |
| INR |
2.2±0.9 |
| Hematocrit |
25.8±3.57 mg/dL |
| Platelet Count |
261(166-470) thousand |
| Aspirin |
11 (92%) |
| Red blood cell transfusion |
2 (20%) |
| Fresh frozen plasma transfusion |
2 (20%) |
| Platelet transfusion |
0 |
| M: Male; F: Female; BMI: Body mass index; ICM: Ischemic cardiomyopathy; NICM: Nonischemic cardiomyopathy; BTT: Bridge to transplantation; INTERMACS: Interagency Registry for Mechanically Assisted Circulatory Support; MCS: Mechanical circulatory support; INR: International normalized ratio |
|
